Self-assessment of medical abortion outcome using symptoms and home pregnancy testing
- PMID: 29242085
- DOI: 10.1016/j.contraception.2017.12.004
Self-assessment of medical abortion outcome using symptoms and home pregnancy testing
Abstract
Objectives: We aimed to evaluate compliance with a strategy to enable medical abortion patients to assess treatment outcome on their own and decide whether to seek clinical follow-up.
Study design: We enrolled women undergoing medical abortion with mifepristone and misoprostol at three clinics in the United States. Each participant was instructed to perform a multilevel pregnancy test (MLPT) 7 days after mifepristone ingestion and to contact the clinic immediately if the test indicated a possible ongoing pregnancy or if specified symptoms occurred. A telephone call was scheduled 14 days after mifepristone ingestion to evaluate participants who had not contacted the clinic earlier.
Results: Of the 343 enrolled participants, 90 (26%) did not provide sufficient follow-up information for analysis of compliance with instructions. Of the 253 (74%) who did, 218 (86%) implemented the self-assessment strategy as instructed, 20 (7.9%) failed to report a non-reassuring MLPT result, 4 (1.6%) failed to promptly report symptoms that the study clinician subsequently judged to require evaluation, and 11 (4.3%) did not perform the MLPT. We ascertained abortion outcomes for 239 (70%) of the enrolled women, of whom three were diagnosed with ongoing pregnancies. One other participant was hospitalized for bleeding. All four women had implemented the strategy correctly. Of the 219 enrolled participants (64%) who provided opinions, 170 (78%) indicated that most could use the MLPT to decide whether they are "OK" after an abortion. We did not ascertain opinions from 124 enrolled participants (36%).
Conclusions: At least two thirds of enrolled participants correctly implemented a strategy using symptom evaluation and a MLPT to assess their own medical abortion outcomes. No ongoing pregnancies occurred in women documented not to have implemented the strategy as intended. Perceived feasibility of the self-assessment approach was high. Implications Statement The common practice of scheduling a clinical contact after every medical abortion may not be necessary to ensure safety; enabling patients to determine for themselves whether or not a contact is needed can be a reasonable approach.
Trial registration: ClinicalTrials.gov NCT02570204.
Keywords: Medical abortion; Ongoing pregnancy; Pregnancy test; Self-assessment.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
Randomized trial assessing home use of two pregnancy tests for determining early medical abortion outcomes at 3, 7 and 14days after mifepristone.Contraception. 2016 Aug;94(2):115-21. doi: 10.1016/j.contraception.2016.04.001. Epub 2016 Apr 8. Contraception. 2016. PMID: 27067706 Clinical Trial.
-
Use of an at-home multilevel pregnancy test and an automated call-in system to follow-up the outcome of medical abortion.Int J Gynaecol Obstet. 2019 Jan;144(1):97-102. doi: 10.1002/ijgo.12679. Epub 2018 Oct 8. Int J Gynaecol Obstet. 2019. PMID: 30221366
-
Self-administered multi-level pregnancy tests in simplified follow-up of medical abortion in Tunisia.BMC Womens Health. 2016 Jul 30;16:49. doi: 10.1186/s12905-016-0327-1. BMC Womens Health. 2016. PMID: 27475998 Free PMC article. Clinical Trial.
-
Abortion with mifepristone and misoprostol: regimens, efficacy, acceptability and future directions.Am J Obstet Gynecol. 2000 Aug;183(2 Suppl):S44-53. doi: 10.1067/mob.2000.107950. Am J Obstet Gynecol. 2000. PMID: 10944369 Review.
-
Follow-up strategies to confirm the success of medical abortion of pregnancies up to 10 weeks' gestation: a systematic review with meta-analyses.Am J Obstet Gynecol. 2020 Jun;222(6):551-563.e13. doi: 10.1016/j.ajog.2019.11.1244. Epub 2019 Nov 9. Am J Obstet Gynecol. 2020. PMID: 31715147
Cited by
-
Improving experience of medical abortion at home in a changing therapeutic, technological and regulatory landscape: a realist review.BMJ Open. 2022 Nov 16;12(11):e066650. doi: 10.1136/bmjopen-2022-066650. BMJ Open. 2022. PMID: 36385017 Free PMC article. Review.
-
Commentary: No-test medication abortion: A sample protocol for increasing access during a pandemic and beyond.Contraception. 2020 Jun;101(6):361-366. doi: 10.1016/j.contraception.2020.04.005. Epub 2020 Apr 16. Contraception. 2020. PMID: 32305289 Free PMC article. No abstract available.
-
Special ambulatory gynecologic considerations in the era of coronavirus disease 2019 (COVID-19) and implications for future practice.Am J Obstet Gynecol. 2020 Sep;223(3):372-378. doi: 10.1016/j.ajog.2020.06.006. Epub 2020 Jun 6. Am J Obstet Gynecol. 2020. PMID: 32522513 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous